This content is machine translated Atopic dermatitis Modern systems therapeutics specifically regulate the excessive immune response The therapeutic landscape for patients with moderate to severe atopic dermatitis is changing. In the multifactorial pathogenesis of this chronic recurrent dermatosis, an impaired immune response plays a central role.…
View Post 4 min This content is machine translated IgE autoreactivity in atopic dermatitis. Study shows association with type 2 comorbidities Atopic dermatitis (AD) is one of the type 2 dominant diseases, caused by complex interactions between genetics and the environment. The role of autoreactive IgE antibodies (auto-IgE) in the pathophysiology of…
View Post 2 min This content is machine translated Moderate to severe atopic dermatitis “Flares” affect the quality of life Current empirical data underscore the high “burden of disease” in patients with inadequately controlled atopic dermatitis and indicate that there remains a need for highly effective and subgroup-specific systemic therapies.
View Post 4 min This content is machine translated Atopic dermatitis: biologics Dupilumab also effective and safe in under 12-year-olds In Switzerland, the approval of the highly effective biologic Dupilumab in the indication area of atopic dermatitis has so far been limited to adult and adolescent patients aged 12 years…
View Post 3 min This content is machine translated Atopic dermatitis: JAK inhibitors Baricitinib combined with topical steroids achieves high patient benefit When topical steroid therapy alone is not sufficiently effective, patients with atopic dermatitis may benefit greatly from the additional use of the JAK inhibitor baricitinib. This is shown, among other…
View Post 2 min This content is machine translated Digital Health Neurodermatitis patients benefit from Nia App With the new cooperation between aha! Allergy Center Switzerland and Nia Health, more sufferers in Switzerland should use the award-winning app in their daily lives. The focus is on the…
View Post 3 min This content is machine translated World Neurodermatitis Day Using new system therapies in practice – the therapeutic potential is great On the occasion of World Neurodermatitis Day on September 14, 2021, the German Dermatological Society (DDG) and the professional association of German dermatologists (BVDD) pointed out the currently available highly effective…
View Post 5 min This content is machine translated Neurodermatitis in children and adolescents Consistent topical basic care – the foundation of every successful therapy Pathophysiologically, a disturbed skin barrier with a lack of natural moisturizing factors and altered lipid and protein composition plays a key role in atopic dermatitis. Restoring physiological skin barrier function…
View Post 12 min This content is machine translated Atopic dermatitis Digital support options for treatment The terms atopic dermatitis, atopic eczema and atopic dermatitis stand for a global skin disease, with children and adolescents being the most frequently affected. In 2020, a systematic review included… CME-Test
View Post 4 min This content is machine translated Atopic dermatitis Longer recurrence-free interval due to adequate basic therapy Eczema is the most common skin condition seen in family practice and is one of the typical symptoms of atopic dermatitis. A disturbed skin barrier is common to all eczemas…
View Post 10 min This content is machine translated Atopic dermatitis Non-drug therapeutic approaches outside alternative medicine Basic therapy, UV light therapy, implementation of skin disinfection and other measures can lead to relief from neurodermatitis. Regarding climatic therapy, it has been shown that a reduced allergen concentration above…
